In this post I describe an idea for using SNP fingerprinting for single-cell RNA-Seq to identify which sample each individual cell comes from in a multiplexed library prep. The reason for my thinking about this is that single-cell experiments are expensive. Although the cost-per-cell can […]
Andrew Adey’s group at the Department of Molecular & Medical Genetics in Oregon Health & Science University published SCI-seq in Nature Methods earlier this week (it has been on the BioRxiv since July). SCI-Seq is a method for single-cell copy number analysis that is likely […]
Introducing NovaSeq This is the second part of my “everything you wanted to know about NovaSeq blog and in it I’ll finish up by discussing some of the challenges the instrument presents for Core Labs and their users, and the costs of running NovaSeq compared to […]
Introducing NovaSeq This is the first part of a 2 part blog. Part 1 “everything you wanted to know about NovaSeq” covers the technical aspects of NovaSeq, Illumina’s latest sequencer launched on Jan 9th 2017. The instrument is very clearly the next proper step in Illumina technology, which […]
I’m not in tomorrow as I’m off to a funeral so I’ll not be writing anymore about the new sequencer from Illumina till later in the week. But here’s my initial thoughts… Illumina’s presentation at JP Morgan is over and they’ve certainly delivered. NovaSeq is the latest […]
I thought I’d follow Keith’s lead and make my own suggestions for what might be revealed during Illumina’s presentation at this years JPMorgan event. All the great announcements, by Illumina and everyone else, used to be made at the AGBT meeting in February and that gave […]
Merry Christmas to everyone who’s read this blog last year. I hope you are looking forward to 2017 as much as I, there’s some cool stuff coming in 2017. James.
I’m predicting that 2017 will be the breakthrough year for nanopore sequencing. Having seen what’s been going on over the last 12-24 months I’m pretty confident that we’ll see at least one NGS niche being taken over by Nanopore sequencing in 2017. Whether this will […]
Breast cancer researchers publish a lot of papers, and a large number of those will include some genomics, variant identification, RNA-Seq, ChIP-Seq, etc. Increasingly research is being carried out on patient derived material, but cell lines are still a vital part of much of the […]
Illumina’s patterned flowcells were a major change to their core technology. It was a change that was a long time coming, with patterned flowcells being discussed many years ago at AGBT. Any major change can throw up nasty surprises, and unfortunately the new ExAmp clustering […]
